Background: The patterns on diffusion-weighted (DWI) MRI may be predictive of stroke etiology. In this retrospective study, we assessed whether DWI bright lesions termed ‘pearls’ predicted the presence of large-vessel arterial stenosis as the etiology of stroke. Methods: All stroke and transient ischemic attack admissions to an academic hospital over a 2-year period were reviewed. Patients without DWI, with hemorrhagic strokes or with nonvascular disease were excluded. Two vascular neurologists reviewed medical records and classified the probable stroke etiology by modified TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria. Another investigator, blinded to the clinical diagnoses, reviewed MRI images only. A ‘pearl’ was defined as a DWI bright lesion 20 mm or less in diameter. A ’string of pearls’ was defined as 3 or more pearls in a line found unilaterally in the anterior circulation. ‘Scattered pearls’ were classified as 3 or more pearls distributed such that no single line could connect them, also found unilaterally in the anterior circulation. Results: Fifty-six percent of the patients with either ‘pearls’ sign were classified as TOAST 1 or 2, with this classification only found in 33% of the patients with other DWI patterns (p = 0.0009). If either ‘pearl’ sign was seen on MRI, a patient was 2.65 times (95% CI = 1.32–5.32) more likely to have either extracranial or intracranial large-vessel stenosis. Conclusions: The presence of either ‘string of pearls’ or ‘scattered pearls’ on MRI was associated with an independently determined mechanism of intracranial or extracranial arterial stenosis. In patients with acute stroke distributions consistent with either of these patterns, additional vascular imaging should be considered.

1.
Madden KP, Karanjia PN, Adams HP Jr, Clarke WR: Accuracy of initial stroke subtype diagnosis in the toast study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology 1995;45:1975–1979.
2.
Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J, Wendland MF, Weinstein PR: Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330–346.
3.
Warach S, Chien D, Li W, Ronthal M, Edelman RR: Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992;42:1717–1723.
4.
Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR: Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231–241.
5.
Altieri M, Metz RJ, Muller C, Maeder P, Meuli R, Bogousslavsky J: Multiple brain infarcts: clinical and neuroimaging patterns using diffusion-weighted magnetic resonance. Eur Neurol 1999;42:76–82.
6.
Baird AE, Lovblad KO, Schlaug G, Edelman RR, Warach S: Multiple acute stroke syndrome: marker of embolic disease? Neurology 2000;54:674–678.
7.
Roh JK, Kang DW, Lee SH, Yoon BW, Chang KH: Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke 2000;31:688–694.
8.
Koennecke HC, Bernarding J, Braun J, Faulstich A, Hofmeister C, Nohr R, Leistner S, Marx P: Scattered brain infarct pattern on diffusion-weighted magnetic resonance imaging in patients with acute ischemic stroke. Cerebrovasc Dis 2001;11:157–163.
9.
Kang DW, Chu K, Ko SB, Kwon SJ, Yoon BW, Roh JK: Lesion patterns and mechanism of ischemia in internal carotid artery disease: a diffusion-weighted imaging study. Arch Neurol 2002;59:1577–1582.
10.
Kang DW, Chalela JA, Ezzeddine MA, Warach S: Association of ischemic lesion patterns on early diffusion-weighted imaging with toast stroke subtypes. Arch Neurol 2003;60:1730–1734.
11.
Lee PH, Bang OY, Oh SH, Joo IS, Huh K: Subcortical white matter infarcts: comparison of superficial perforating artery and internal border-zone infarcts using diffusion-weighted magnetic resonance imaging. Stroke 2003;34:2630–2635.
12.
Engelter ST, Wetzel SG, Radue EW, Rausch M, Steck AJ, Lyrer PA: The clinical significance of diffusion-weighted MR imaging in infratentorial strokes. Neurology 2004;62:574–580.
13.
Bonati LH, Lyrer PA, Wetzel SG, Steck AJ, Engelter ST: Diffusion-weighted imaging, apparent diffusion coefficient maps and stroke etiology. J Neurol 2005;252:1387–1393.
14.
Wessels T, Wessels C, Ellsiepen A, Reuter I, Trittmacher S, Stolz E, Jauss M: Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol 2006;27:35–39.
15.
Warach S, Edelman RR: The ‘string of pearls sign’ – a sign of watershed infarctions by diffusion-weighted MRI. Proc 34th Annu Meet Am Soc Neuroradiol 1996, p 180.
16.
Chalela JA, Kang D-W, Latour LL, Warach S: String of pearls sign on diffusion MRI is associated with large artery atherosclerosis (poster 7). Am Stroke Assoc Int Stroke Conf, Phoenix, 2003.
17.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Toast. Trial of ORG 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
18.
Stata Corp: Stata statistical software release 8.0. College Station, Stata, 2002.
19.
Gottesman RF, Sherman PM, Grega MA, Yousem DM, Borowicz LM Jr, Selnes OA, Baumgartner WA, McKhann GM: Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke 2006;37:2306–2311.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.